“Triple-negative” breast cancers are aggressive malignancies that respond poorly to treatments. Now Sun et al. (2011) find that the activity of the protein tyrosine phosphatase PTPN12 is lost in a large percentage of this breast cancer subtype, offering molecular drivers and possible therapeutic targets for this heterogeneous and intractable cancer
Triple negative breast cancer (TNBC) is a subtype of breast cancer (BC) with a heterogeneous nature ...
Triple-negative breast cancers (TNBCs) are a diverse and heterogeneous group of tumors that by defin...
Breast cancer is the most commonly occurring malignancy and the leading cause of cancer-related deat...
“Triple-negative” breast cancers are aggressive malignancies that respond poorly to treatments. Now ...
SummaryAmong breast cancers, triple-negative breast cancer (TNBC) is the most poorly understood and ...
SummaryAmong breast cancers, triple-negative breast cancer (TNBC) is the most poorly understood and ...
Disruption of the balanced modulation of reversible tyrosine phosphorylation has been implicated in ...
Of the estimated 1 million cases of breast cancer diagnosed annually worldwide, it is estimated that...
Of the estimated 1 million cases of breast cancer diagnosed annually worldwide, it is estimated that...
Triple negative breast cancer is a subtype of breast cancer that lacks expression of an estrogen rec...
Triple negative breast cancer is a subtype of breast cancer that lacks expression of an estrogen rec...
AbstractTriple negative breast cancer (TNBC) is a subtype of breast cancer (BC) with a heterogeneous...
INTRODUCTION: Activation of the phosphatidylinositol 3-kinase (PI3K) pathway in estrogen receptor α ...
Triple-negative breast cancers (TNBC) are characterized by the lack of or reduced expression of the ...
Loss of the tumor suppressor gene PTEN is implicated in breast cancer progression and resistance to ...
Triple negative breast cancer (TNBC) is a subtype of breast cancer (BC) with a heterogeneous nature ...
Triple-negative breast cancers (TNBCs) are a diverse and heterogeneous group of tumors that by defin...
Breast cancer is the most commonly occurring malignancy and the leading cause of cancer-related deat...
“Triple-negative” breast cancers are aggressive malignancies that respond poorly to treatments. Now ...
SummaryAmong breast cancers, triple-negative breast cancer (TNBC) is the most poorly understood and ...
SummaryAmong breast cancers, triple-negative breast cancer (TNBC) is the most poorly understood and ...
Disruption of the balanced modulation of reversible tyrosine phosphorylation has been implicated in ...
Of the estimated 1 million cases of breast cancer diagnosed annually worldwide, it is estimated that...
Of the estimated 1 million cases of breast cancer diagnosed annually worldwide, it is estimated that...
Triple negative breast cancer is a subtype of breast cancer that lacks expression of an estrogen rec...
Triple negative breast cancer is a subtype of breast cancer that lacks expression of an estrogen rec...
AbstractTriple negative breast cancer (TNBC) is a subtype of breast cancer (BC) with a heterogeneous...
INTRODUCTION: Activation of the phosphatidylinositol 3-kinase (PI3K) pathway in estrogen receptor α ...
Triple-negative breast cancers (TNBC) are characterized by the lack of or reduced expression of the ...
Loss of the tumor suppressor gene PTEN is implicated in breast cancer progression and resistance to ...
Triple negative breast cancer (TNBC) is a subtype of breast cancer (BC) with a heterogeneous nature ...
Triple-negative breast cancers (TNBCs) are a diverse and heterogeneous group of tumors that by defin...
Breast cancer is the most commonly occurring malignancy and the leading cause of cancer-related deat...
DOI
Add to ORKG